IBDEI1L5 ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,28141,1,5,0)
 ;;=5^Pneumocystosis
 ;;^UTILITY(U,$J,358.3,28141,2)
 ;;=^95635
 ;;^UTILITY(U,$J,358.3,28142,0)
 ;;=601.9^^162^1792^58
 ;;^UTILITY(U,$J,358.3,28142,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28142,1,4,0)
 ;;=4^601.9
 ;;^UTILITY(U,$J,358.3,28142,1,5,0)
 ;;=5^Prostatitis NOS
 ;;^UTILITY(U,$J,358.3,28142,2)
 ;;=^99489
 ;;^UTILITY(U,$J,358.3,28143,0)
 ;;=590.80^^162^1792^59
 ;;^UTILITY(U,$J,358.3,28143,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28143,1,4,0)
 ;;=4^590.80
 ;;^UTILITY(U,$J,358.3,28143,1,5,0)
 ;;=5^Pyelonephritis NOS
 ;;^UTILITY(U,$J,358.3,28143,2)
 ;;=^101463
 ;;^UTILITY(U,$J,358.3,28144,0)
 ;;=711.00^^162^1792^60
 ;;^UTILITY(U,$J,358.3,28144,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28144,1,4,0)
 ;;=4^711.00
 ;;^UTILITY(U,$J,358.3,28144,1,5,0)
 ;;=5^Septic Joint
 ;;^UTILITY(U,$J,358.3,28144,2)
 ;;=^263780
 ;;^UTILITY(U,$J,358.3,28145,0)
 ;;=461.9^^162^1792^61
 ;;^UTILITY(U,$J,358.3,28145,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28145,1,4,0)
 ;;=4^461.9
 ;;^UTILITY(U,$J,358.3,28145,1,5,0)
 ;;=5^Sinusitis, Acute
 ;;^UTILITY(U,$J,358.3,28145,2)
 ;;=^259080
 ;;^UTILITY(U,$J,358.3,28146,0)
 ;;=473.9^^162^1792^62
 ;;^UTILITY(U,$J,358.3,28146,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28146,1,4,0)
 ;;=4^473.9
 ;;^UTILITY(U,$J,358.3,28146,1,5,0)
 ;;=5^Sinusitis, Chronic
 ;;^UTILITY(U,$J,358.3,28146,2)
 ;;=^123985
 ;;^UTILITY(U,$J,358.3,28147,0)
 ;;=091.0^^162^1792^67
 ;;^UTILITY(U,$J,358.3,28147,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28147,1,4,0)
 ;;=4^091.0
 ;;^UTILITY(U,$J,358.3,28147,1,5,0)
 ;;=5^Syphilis,Primary Genital
 ;;^UTILITY(U,$J,358.3,28147,2)
 ;;=^50581
 ;;^UTILITY(U,$J,358.3,28148,0)
 ;;=097.0^^162^1792^65
 ;;^UTILITY(U,$J,358.3,28148,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28148,1,4,0)
 ;;=4^097.0
 ;;^UTILITY(U,$J,358.3,28148,1,5,0)
 ;;=5^Syphilis,Latent
 ;;^UTILITY(U,$J,358.3,28148,2)
 ;;=^266781
 ;;^UTILITY(U,$J,358.3,28149,0)
 ;;=094.9^^162^1792^66
 ;;^UTILITY(U,$J,358.3,28149,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28149,1,4,0)
 ;;=4^094.9
 ;;^UTILITY(U,$J,358.3,28149,1,5,0)
 ;;=5^Syphilis,Neurosyphilis
 ;;^UTILITY(U,$J,358.3,28149,2)
 ;;=^83026
 ;;^UTILITY(U,$J,358.3,28150,0)
 ;;=097.9^^162^1792^64
 ;;^UTILITY(U,$J,358.3,28150,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28150,1,4,0)
 ;;=4^097.9
 ;;^UTILITY(U,$J,358.3,28150,1,5,0)
 ;;=5^Syphilis NOS
 ;;^UTILITY(U,$J,358.3,28150,2)
 ;;=^116808
 ;;^UTILITY(U,$J,358.3,28151,0)
 ;;=463.^^162^1792^68
 ;;^UTILITY(U,$J,358.3,28151,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28151,1,4,0)
 ;;=4^463.
 ;;^UTILITY(U,$J,358.3,28151,1,5,0)
 ;;=5^Tonsillitis
 ;;^UTILITY(U,$J,358.3,28151,2)
 ;;=^2695
 ;;^UTILITY(U,$J,358.3,28152,0)
 ;;=130.9^^162^1792^69
 ;;^UTILITY(U,$J,358.3,28152,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28152,1,4,0)
 ;;=4^130.9
 ;;^UTILITY(U,$J,358.3,28152,1,5,0)
 ;;=5^Toxoplasmosis NOS
 ;;^UTILITY(U,$J,358.3,28152,2)
 ;;=^120695
 ;;^UTILITY(U,$J,358.3,28153,0)
 ;;=011.90^^162^1792^70
 ;;^UTILITY(U,$J,358.3,28153,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28153,1,4,0)
 ;;=4^011.90
 ;;^UTILITY(U,$J,358.3,28153,1,5,0)
 ;;=5^Tuberculosis
 ;;^UTILITY(U,$J,358.3,28153,2)
 ;;=^122756
 ;;^UTILITY(U,$J,358.3,28154,0)
 ;;=614.2^^162^1792^71
 ;;^UTILITY(U,$J,358.3,28154,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28154,1,4,0)
 ;;=4^614.2
 ;;^UTILITY(U,$J,358.3,28154,1,5,0)
 ;;=5^Tubo-Ovarian Abcess
 ;;^UTILITY(U,$J,358.3,28154,2)
 ;;=^107806
 ;;^UTILITY(U,$J,358.3,28155,0)
 ;;=788.7^^162^1792^74
 ;;^UTILITY(U,$J,358.3,28155,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28155,1,4,0)
 ;;=4^788.7
 ;;
 ;;$END ROU IBDEI1L5
